BW

Better Therapeutics Announces Upcoming Poster Presentation at EASL Congress 2023 in Vienna, Austria

Naim Alkhouri, MD, FAASLD, to Present Findings from Non-alcohol Related Fatty Liver Disease Feasibility StudySAN FRANCISCO--(BUSINESS WIRE)--$BTTX #digitalhealth--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based, novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases, today announced…
Leer más...

Macnica provides motor-specific predictive maintenance services in Asian countries : Mpression Smart Motor Sensor in ASEAN

- Reducing downtime and optimizing maintenance costs for customers in the manufacturing industry -YOKOHAMA, Japan--(BUSINESS WIRE)--Macnica, Inc. (Headquarters: Yokohama City, Kanagawa Prefecture; President: Kazumasa Hara; hereinafter Macnica), a total service and solution provider in semiconductors, networks, cybersecurity and AI/IoT, has launched the Mpression Smart Motor Sensor, a solution comprising products…
Leer más...

PsiQuantum publishes paper projecting a 700x reduction in the computational resource requirements for breaking Elliptic Curve Cryptography using a fault tolerant quantum computer

PsiQuantum’s latest paper describes a more efficient method to break Elliptic Curve Cryptography (ECC) which is widely used for secure communications. This approach uses techniques especially applicable to photonic architectures, and reduces the number of gate operations required to break an ECC key by up to 80% as well as…
Leer más...

CASTLE ALERT: Bragar Eagel & Squire, P.C. is Investigating Castle Biosciences, Inc. on Behalf of Castle Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--#A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Castle Biosciences, Inc. (“Castle” or the “Company”) (NASDAQ: CSTL) on behalf of Castle stockholders. Our investigation concerns whether Castle has violated the federal securities laws and/or engaged in other unlawful business…
Leer más...

Nintendo News: Fire Emblem for Game Boy Advance Rekindles the Flames of Battle on Nintendo Switch Online + Expansion Pack June 22

REDMOND, Wash.--(BUSINESS WIRE)--#nintendoswitch--Plan your strategy and draw your steel, because smoldering rivalries are set to burn bright once more on the Nintendo Switch™ system! Starting June 22, Fire Emblem™ – also known as Fire Emblem: The Blazing Blade – will be available for everyone with a Nintendo Switch Online +…
Leer más...

DUTCH BROS ALERT: Bragar Eagel & Squire, P.C. is Investigating Dutch Bros Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--#A--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Dutch Bros Inc. (NYSE: BROS) on behalf of long-term stockholders following a class action complaint that was filed against Dutch Bros on March 2, 2023 with a Class Period from March…
Leer más...

EPAM ALERT: Bragar Eagel & Squire, P.C. is Investigating EPAM Systems, Inc. on Behalf of EPAM Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--#A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against EPAM Systems, Inc. (“EPAM” or the “Company”) (NYSE: EPAM) on behalf of EPAM stockholders. Our investigation concerns whether EPAM has violated the federal securities laws and/or engaged in other unlawful business…
Leer más...

DZS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against DZS Inc. and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--#A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against DZS Inc. (“DZS” or the “Company”) (NASDAQ: DZSI) in the United States District Court for the Eastern District of Texas on behalf of all persons and…
Leer más...

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against BeiGene, Ltd. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)--$BGNE #BGNE--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of BeiGene, Ltd. (“BeiGene” or “the Company”) (NASDAQ: BGNE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements…
Leer más...

U.S. Food and Drug Administration Approves Addition of Positive Data from Phase 3 VALOR-HCM Study to CAMZYOS® (mavacamten) Label

CAMZYOS is the first and only FDA-approved cardiac myosin inhibitor that specifically targets the underlying source of obstructive HCM VALOR-HCM is the second Phase 3 trial in which CAMZYOS demonstrated significant improvement in symptoms of obstructive HCMPRINCETON, N.J.--(BUSINESS WIRE)--$BMY #BMS--Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food…
Leer más...